论文部分内容阅读
目的观察静脉用蔗糖铁联合促红细胞生成素治疗维持性血液透析慢性伴肾性贫血患者的疗效。方法选取2009年10月至2012年9月在六盘水水矿总医院维持性血液透析伴慢性肾性贫血患者50例,给予静脉滴注蔗糖铁,100 mg/次,每周2次,直至补完总铁量,改成维持治疗,每2周1次,100 mg/次,同时静脉用重组人促红细胞生成素;治疗前后对照观察以明确静脉应用铁剂的疗效和安全性。结果蔗糖铁联合促红细胞生成等治疗维持性血液透析伴慢性肾性贫血患者,效果明显,且无明显不良反应发生。结论蔗糖铁联合促红素治疗维持性血液透析伴慢性肾性贫血患者有效、安全,患者依从性好。
Objective To observe the effect of intravenous infusion of sucrose and iron combined with erythropoietin on chronic hemodialysis patients with renal anemia. Methods Fifty patients with maintenance hemodialysis and chronic renal anemia in Liupanshui Shuiying General Hospital from October 2009 to September 2012 were given intravenous drip of sucrose and iron 100 mg twice daily until the end Total iron, changed to maintenance treatment, once every two weeks, 100 mg / time intravenous recombinant human erythropoietin; control before and after treatment to determine the efficacy and safety of intravenous iron. Results Sucrose iron combined with erythropoiesis and other maintenance hemodialysis patients with chronic renal anemia, the effect was obvious, and no significant adverse reactions. Conclusion Sucrose iron combined with erythropoietin is effective and safe in maintenance hemodialysis patients with chronic renal anemia and good compliance in patients.